AHRQ Tech Appraisal, Blues’ TEC Reveal Reservations With TMR Clinical Data
This article was originally published in The Gray Sheet
Executive Summary
The Blues' Technology Evaluation Center shares CMS' apparent dissatisfaction with existing clinical evidence for transmyocardial revascularization (TMR) performed with coronary artery bypass surgery
You may also be interested in...
TMR During Coronary Bypass: CMS Convenes MCAC To Reconsider Coverage
CMS should gather more prospective clinical trial data on transmyocardial revascularization during cardiac bypass surgery (TMR + CABG) before considering changes to its TMR Medicare coverage policy, the Society of Thoracic Surgery argues
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.